Benzo[a]pyrene led to Metabolic dysfunction-associated steatotic liver disease by promoting hepatic lipid accumulation through the CYP1B1-mediated suppression of lipophagy (Bu et al., 2024). This evidence concerns the gene CYP1B1 and liver disorder.